Musculoskeletal Specialty Group Remit
The remit of the Musculoskeletal Specialty Group is to support to a national portfolio of structured research studies that will enhance our understanding of:
a) normal structure and function of joints, bone, muscle and cartilage
b) diseases resulting from disordered musculoskeletal structure and function including aetiopathogenesis, investigation, diagnosis, monitoring, treatment and prevention
The Musculoskeletal Specialty Group portfolio includes investigator initiated and commercial studies on:
- Inflammatory joint disease including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, undifferentiated early inflammatory arthritis, gout and other forms of crystal arthritis
- Non-inflammatory joint disease including osteoarthritis
- Non-inflammatory connective tissue disease including disorders of ligaments and tendons, joint hypermobility syndrome and Marfan’s syndrome
Metabolic bone disease including osteoporosis, vitamin D related bone disease and Paget’s disease Musculoskeletal pain disorders including back pain, knee pain, shoulder pain and chronic widespread pain Elective orthopaedic surgery Non-pharmacologic therapeutic modalities including physiotherapy, occupational therapy, patient education and psychological therapies
